Lundbeck makes ATryn available

DEERFIELD - Lundbeck Inc., a wholly owned subsidiary of H. Lundbeck in Denmark, announced Wednesday that ATryn is now available in the United States.

In February 2009, the U.S. Food and Drug Administration granted marketing approval of ATryn for the prevention of certain health events in patients with a rare and potentially fatal blood clotting disorder called hereditary antithrombin deficiency.